drugset / Trial / NCT00002442
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
Open-labelTreatment
Summary
The purpose of this study is to compare the safety and effectiveness of 2 dosing schedules (once daily vs twice daily) of lamivudine (3TC) given with stavudine (d4T) and either indinavir (IDV) or nelfinavir (NFV) for 24 weeks.
Timeline
- Start
- 1999-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamivudine | Other / unclassified | 150 mg | — |
| Subject | Lamivudine | Other / unclassified | 300 mg | — |
| Background | INDINAVIR ANHYDROUS | Other / unclassified | — | — |
| Background | Nelfinavir | Other / unclassified | — | — |
| Background | Stavudine | Other / unclassified | — | — |